Systemic mycoses in the immunocompromised host: an update in antifungal therapy

This publication has 157 references indexed in Scilit:

• Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort
  European Journal of Clinical Microbiology & Infectious Diseases, 2010
• Invasive Aspergillosis in 2002: An Update
  European Journal of Clinical Microbiology & Infectious Diseases, 2002
• Intravenous Itraconazole Followed by Oral Itraconazole in the Treatment of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies, Chronic Granulomatous Disease, or AIDS
  Clinical Infectious Diseases, 2001
• Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia
  Clinical Infectious Diseases, 2001
• A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia
  Clinical Infectious Diseases, 2000
• Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis
  Clinical Infectious Diseases, 1999
• Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients
  European Journal of Clinical Microbiology & Infectious Diseases, 1997
• Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial
  European Journal Of Cancer, 1996
• Diagnosis of invasive mycoses in severely immunosuppressed patients
  Annals of Hematology, 1993
• Effects of cilofungin (LY121019) on carbohydrate and sterol composition ofCandida albicans
  European Journal of Clinical Microbiology & Infectious Diseases, 1989